Cargando…
Methylation profiling and evaluation of demethylating therapy in renal cell carcinoma
BACKGROUND: Despite therapeutic advances in targeted therapy, metastatic renal cell carcinoma (RCC) remains incurable for the vast majority of patients. Key molecular events in the pathogenesis of RCC include inactivation of the VHL tumour suppressor gene (TSG), inactivation of chromosome 3p TSGs im...
Autores principales: | Ricketts, Christopher J, Morris, Mark R, Gentle, Dean, Shuib, Salwati, Brown, Michael, Clarke, Noel, Wei, Wenbin, Nathan, Paul, Latif, Farida, Maher, Eamonn R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848591/ https://www.ncbi.nlm.nih.gov/pubmed/24034811 http://dx.doi.org/10.1186/1868-7083-5-16 |
Ejemplares similares
-
Identification of Candidate Tumour Suppressor Genes Frequently Methylated in Renal Cell Carcinoma
por: Morris, Mark R., et al.
Publicado: (2010) -
CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma
por: McRonald, Fiona E, et al.
Publicado: (2009) -
Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas
por: Hill, Victoria K, et al.
Publicado: (2014) -
Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma
por: Morris, M R, et al.
Publicado: (2008) -
Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility
por: Astuti, Dewi, et al.
Publicado: (2011)